Crossmark

The key entity of a DCAR agonist, phosphatidylinositol mannoside Ac<sub>1</sub>PIM<sub>1</sub>: its synthesis and immunomodulatory function

Crossref DOI link: https://doi.org/10.1039/C9OB02724F

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Arai, Yohei

Torigoe, Shota

Matsumaru, Takanori

Yamasaki, Sho

Fujimoto, Yukari https://orcid.org/0000-0001-5320-3192
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (JP17H02207, JP18H04426, JP19H04815, JP17H05800, JP19J13192)

Japan Agency for Medical Research and Development (JP19ae0101052, JP19gm0910010, JP19ak0101070, JP19fk0108075)

Takeda Science Foundation
License Information

Accepted Manuscript valid from 2021-04-22
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Yukari Fujimoto (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 24 December 2019; Accepted 21 April 2020; Accepted Manuscript published 22 April 2020; Advance Article published 1 May 2020; Version of Record published 20 May 2020